Sigma Healthcare Limited
SIG
Rang in aandelen
#1028
Sigma Healthcare Limited, together with its various operating divisions,... Sigma Healthcare Limited, together with its various operating divisions, primarily engages in the wholesale supply and distribution of pharmaceutical goods across Australia. The company also manages a significant network of approximately 1,200 retail pharmacies, encompassing both independent outlets and prominent brands such as Amcal, Discount Drug Stores, Guardian, WholeLife, and PharmaSave. Beyond retail, its comprehensive service portfolio includes wholesale provisions for hospital pharmacies, as well as crucial dose administration aid services delivered to the aged care sector, community pharmacies, and directly to individuals in their homes. Furthermore, Sigma offers advanced technology solutions and data analytics, alongside product development and support for its range of private and exclusive label products. It is also a key supplier of medical consumables and devices to a broad spectrum of customers, from pharmacies and aged care facilities to hospitals and clinics. In addition, the company provides contract logistics services to pharmaceutical manufacturers and other supply partners. Established in 1912, Sigma Healthcare Limited maintains its corporate headquarters in Rowville, Australia.
Aandeelprijs
$2.00
Marktkapitalisatie
$22.96B
Verandering (1 dag)
0.53%
Verandering (1 jaar)
3.13%
Land
AU
Handel Sigma Healthcare Limited (SIG)
Categorie
Healthcare
P/S-ratio voor Sigma Healthcare Limited (SIG)
P/S-ratio op October 2026 TTM: 2.99
Volgens de meest recente financiële rapporten en aandelenkoers van Sigma Healthcare Limited is de huidige P/S-ratio (TTM) 2.99. Eind 2024 had het bedrijf een P/S-ratio van 0.32.
P/S-ratiohistoriek voor Sigma Healthcare Limited van 2001 tot 2026
P/S-ratio aan het einde van elk jaar
| Jaar | P/S-ratio | Wijzigen |
|---|---|---|
| 2026 (TTM) | 2.99 | 224.91% |
| 2025 | 0.92 | 190.21% |
| 2024 | 0.32 | 102.29% |
| 2023 | 0.16 | 33.16% |
| 2022 | 0.12 | -34.06% |
| 2021 | 0.18 | 8.04% |
| 2020 | 0.17 | 35.77% |
| 2019 | 0.12 | -39.38% |
| 2018 | 0.20 | -22.92% |
| 2017 | 0.26 | 15.54% |
| 2016 | 0.23 | -8.80% |
| 2015 | 0.25 | 29.84% |
| 2014 | 0.19 | -38.78% |
| 2013 | 0.31 | 41.21% |
| 2012 | 0.22 | 37.27% |
| 2011 | 0.16 | -34.35% |
| 2010 | 0.24 | -52.50% |
| 2009 | 0.52 | -22.64% |
| 2008 | 0.67 | -48.44% |
| 2007 | 1.29 | -23.81% |
| 2006 | 1.70 | -86.50% |
| 2004 | 12.56 | -21.73% |
| 2003 | 16.05 | -5.84% |
| 2002 | 17.05 | -44.42% |
| 2001 | 30.67 | 0.00% |
P/S-ratio voor vergelijkbare bedrijven of concurrenten
| Bedrijf | P/S-ratio | Verschil in P/S-ratio | Land |
|---|---|---|---|
| 0.28 | -90.73% |
US
|
|
| - | - |
US
|
|
| 0.23 | -92.45% |
US
|
|
| - | - |
US
|
|
| 0.70 | -76.55% |
US
|
